🇺🇸 Pragabalin in United States

10 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Anaemia — 1 report (10%)
  2. Asthenia — 1 report (10%)
  3. Balance Disorder — 1 report (10%)
  4. Blood Bicarbonate Decreased — 1 report (10%)
  5. Blood Magnesium Decreased — 1 report (10%)
  6. Covid-19 — 1 report (10%)
  7. Deafness Bilateral — 1 report (10%)
  8. Dyspnoea — 1 report (10%)
  9. Gastrointestinal Disorder — 1 report (10%)
  10. Intentional Product Use Issue — 1 report (10%)

Source database →

Pragabalin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is Pragabalin approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Pragabalin in United States?

Baskent University is the originator. The local marketing authorisation holder may differ — check the official source linked above.